epichlorohydrin has been researched along with Diabetes Mellitus, Type 2 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, J; Futami-Suda, S; Hashimoto, M; Igari, Y; Kigawa, Y; Nakano, H; Oba, K; Suzuki, T; Tsunoda-Kubota, M; Watanabe, K | 1 |
| Hansen, M; Knop, FK; Sonne, DP | 1 |
| Gluud, LL; Hansen, M; Knop, FK; Mikkelsen, KH; Sonne, DP; Vilsbøll, T | 1 |
| Aso, Y; Inukai, T; Matsumoto, S; Suetsugu, M; Takebayashi, K | 1 |
| Miyamori, I; Suzuki, J; Takahashi, S; Zenimaru, Y | 1 |
| Kadonosono, K; Kaneko, T; Kawaguchi, J; Morita, S; Shigematu, E; Terauchi, Y; Yamakawa, T | 1 |
| Handelsman, Y | 1 |
| Awata, T; Hosaka, T; Inukai, K; Katayama, S; Kurihara, S; Nakamoto, H; Neda, T; Ono, H | 1 |
| Kadonosono, K; Okamura, A; Takano, T; Utsunomiya, H; Yamakawa, T | 1 |
| Futami, S; Igari, Y; Kigawa, Y; Matsumura, N; Nakano, H; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K | 1 |
| Babaya, N; Fujisawa, T; Hiromine, Y; Ikegami, H; Itoi-Babaya, M; Kawabata, Y; Kobayashi, M; Nojima, K; Noso, S; Ogihara, T; Shibata, M; Yamaji, K | 1 |
| Futami-Suda, S; Igari, Y; Kigawa, Y; Matsumura, N; Nakano, H; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K | 1 |
| Futami-Suda, S; Igari, Y; Kigawa, Y; Matsumura, N; Nakano, H; Oba, K; Ouchi, M; Suzuki, K; Suzuki, T; Watanabe, K; Yasuoka, H | 1 |
| Futami-Suda, S; Kigawa, Y; Nakano, H; Norose, J; Oba, K; Ouchi, M; Sekimizu, K; Suzuki, K; Suzuki, T; Yoshimatsu, H | 1 |
3 review(s) available for epichlorohydrin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.
Topics: Bile Acids and Salts; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Gastric Emptying; Glycated Hemoglobin; Humans; Hypercholesterolemia; Hypoglycemic Agents; Imidazoles; Incretins; Lipid Metabolism; Male; Resins, Synthetic; Signal Transduction; Treatment Outcome | 2014 |
Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials.
Topics: Bile Acids and Salts; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Epichlorohydrin; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Imidazoles; Randomized Controlled Trials as Topic; Reproducibility of Results; Resins, Synthetic; Sequestering Agents | 2017 |
Role of bile acid sequestrants in the treatment of type 2 diabetes.
Topics: Allylamine; Bile Acids and Salts; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Diabetes Mellitus, Type 2; Epichlorohydrin; Hypolipidemic Agents; Imidazoles; Resins, Synthetic | 2011 |
4 trial(s) available for epichlorohydrin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.
Topics: C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Enzyme-Linked Immunosorbent Assay; Epichlorohydrin; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Imidazoles; Male; Middle Aged; Oxidative Stress; Peptide Fragments; Prospective Studies; Pyrimidines; Resins, Synthetic; Retinol-Binding Proteins; Rosuvastatin Calcium; Sulfonamides | 2009 |
Hypoglycemic effects of colestimide on type 2 diabetic patients with obesity.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hypoglycemic Agents; Imidazoles; Insulin Resistance; Male; Middle Aged; Obesity; Pilot Projects; Resins, Synthetic; Treatment Outcome | 2012 |
Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia.
Topics: Aged; Anticholesteremic Agents; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycated Hemoglobin; Hemoglobins; Humans; Hypercholesterolemia; Imidazoles; Insulin Resistance; Male; Middle Aged; Pravastatin; Resins, Synthetic | 2007 |
Blood glucose-lowering activity of colestimide in patients with type 2 diabetes and hypercholesterolemia: a case-control study comparing colestimide with acarbose.
Topics: Acarbose; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycoside Hydrolase Inhibitors; Humans; Hypercholesterolemia; Hypoglycemic Agents; Imidazoles; Lipids; Male; Resins, Synthetic | 2006 |
7 other study(ies) available for epichlorohydrin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
What characteristics at baseline are associated with the glucose-lowering effect of colestimide in patients with type 2 diabetes and hypercholesterolemia according to response to treatment?
Topics: Aged; Blood Glucose; Body Mass Index; Cholelithiasis; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycated Hemoglobin; Humans; Hypercholesterolemia; Hypoglycemic Agents; Imidazoles; Male; Middle Aged; Pilot Projects; Regression Analysis; Resins, Synthetic; Time Factors; Treatment Outcome; Triglycerides | 2013 |
[A case of type 2 diabetes mellitus associated with familial hypercholesterolemia confirming the improvement of blood glucose control by colestimide].
Topics: Aged; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hyperlipoproteinemia Type II; Imidazoles; Resins, Synthetic | 2009 |
Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia.
Topics: Aged; Atorvastatin; Blood Glucose; Comorbidity; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Hypercholesterolemia; Hypoglycemic Agents; Imidazoles; Lipids; Male; Middle Aged; Multivariate Analysis; Pravastatin; Pyrroles; Quinolines; Resins, Synthetic; Retrospective Studies; Treatment Outcome | 2011 |
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Blood Glucose; Body Weight; Carrier Proteins; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Epichlorohydrin; Fasting; Fatty Liver; Humans; Hyperlipidemias; Imidazoles; Insulin Resistance; Membrane Glycoproteins; Mice; Obesity; Resins, Synthetic; Weight Gain | 2007 |
Effects of colestimide on blood glucose-lowering activity and body weight in patients with type 2 diabetes and hypercholesterolemia.
Topics: Anion Exchange Resins; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Epichlorohydrin; Humans; Hypercholesterolemia; Imidazoles; Lipids; Resins, Synthetic | 2007 |
Colestimide lowers plasma glucose levels and increases plasma glucagon-like PEPTIDE-1 (7-36) levels in patients with type 2 diabetes mellitus complicated by hypercholesterolemia.
Topics: Anion Exchange Resins; Blood Glucose; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Glucagon-Like Peptide 1; Humans; Hypercholesterolemia; Imidazoles; Lipids; Male; Middle Aged; Resins, Synthetic | 2007 |
Lack of relationship between blood glucose-lowering activity of colestimide and serum cholecystokinin (CCK) concentrations in patients with type 2 diabetes.
Topics: Aged; Anion Exchange Resins; Blood Glucose; Cholecystokinin; Diabetes Mellitus, Type 2; Epichlorohydrin; Female; Humans; Hypercholesterolemia; Imidazoles; Male; Resins, Synthetic | 2008 |